WELLINGTON MANAGEMENT CO LLP 13D/13G Filings for Rigel Pharmaceuticals, Inc. (RIGL)

WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Rigel Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-09-10
08:54 am
Sale		 2021-08-31 13G Rigel Pharmaceuticals, Inc.
RIGL		 WELLINGTON MANAGEMENT CO LLP 140,620
0.820%		 -979,237decrease
(-87.44%)		 Filing
2021-02-04
11:42 am
Sale		 2020-12-31 13G Rigel Pharmaceuticals, Inc.
RIGL		 WELLINGTON MANAGEMENT CO LLP 1,119,857
6.630%		 -560,869decrease
(-33.37%)		 Filing